Cargando…
Oral polyphenol-armored nanomedicine for targeted modulation of gut microbiota–brain interactions in colitis
Developing oral nanomedicines that suppress intestinal inflammation while modulating gut microbiota and brain interactions is essential for effectively treating inflammatory bowel disease. Here, we report an oral polyphenol-armored nanomedicine based on tumor necrosis factor–α (TNF-α)–small interfer...
Autores principales: | He, Huan, Qin, Qiaozhen, Xu, Fang, Chen, Yitong, Rao, Shuquan, Wang, Chao, Jiang, Xiaoxia, Lu, Xiong, Xie, Chaoming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219598/ https://www.ncbi.nlm.nih.gov/pubmed/37235662 http://dx.doi.org/10.1126/sciadv.adf3887 |
Ejemplares similares
-
Disruption of autophagy by increased 5-HT alters gut microbiota and enhances susceptibility to experimental colitis and Crohn’s disease
por: Haq, Sabah, et al.
Publicado: (2021) -
Polydopamine-based nanomedicines for efficient antiviral and secondary injury protection therapy
por: Yin, Na, et al.
Publicado: (2023) -
Home-site advantage for host species–specific gut microbiota
por: Sprockett, Daniel D., et al.
Publicado: (2023) -
Biointerface mineralization generates ultraresistant gut microbes as oral biotherapeutics
por: Geng, Zhongmin, et al.
Publicado: (2023) -
In vivo hitchhiking of immune cells by intracellular self-assembly of bacteria-mimetic nanomedicine for targeted therapy of melanoma
por: Gao, Cheng, et al.
Publicado: (2022)